neurodegeneration

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

Dale Schenk, who worked to develop a vaccine for Alzheimer’s disease, has passed away at age 59.

Allen Roses, a professor of neurobiology at Duke University School of Medicine, has passed away at age 73.

Mineral nanoparticles similar to those that have been associated with Alzheimer’s disease may enter the brain through the inhalation of polluted air.

Bird brains might tell us a lot about how human brains malfunction in diseases like Parkinson's and Alzheimer's.

Researchers use optogenetics to induce recall in an Alzheimer’s mouse model, suggesting the disease may not destroy memories permanently.

Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Examining the brains of seven patients who died of the prion disease called Creutzfeldt–Jakob, researchers find signs of Alzheimer’s pathology. 

Repeated exposure to explosions can damage the cerebellum in combat veterans and mouse models alike.

In his search for effective therapies for Parkinson’s disease, Lorenz Studer is uncovering pluripotency switches and clues to what makes cells age.

The cancer-related protein BRCA1 is important for learning and memory in mice and is depleted in the brains of Alzheimer’s patients, according to a study.

Using autoantibodies as biomarkers, researchers could soon identify people at the highest risk of developing neurodegenerative diseases much earlier than existing methods.

Data on the links between ALS and the chemical have been contradictory, but the latest study suggests undertakers are at risk.

Young neurons in the adult human brain are likely critical to its function.

Harvard Professor Marc Weisskopf discusses the potential link between formaldehyde and ALS.

Researchers uncover evidence that a retrovirus embedded within the human genome may play a role in the pathology of amyotrophic lateral sclerosis. 

Mental agility in women deteriorates at twice the rate of that in men, according to a study of people with mild cognitive impairment.

Deep-brain stimulation may effectively treat slow movement, tremor, and rigidity in Parkinson’s patients by reducing synchronicity of neural activity in the motor cortex.

An enzyme that cleaves tau protein in acidic cellular conditions may trigger early events in Alzheimer’s disease.

Blocking activity of a kinase in a mouse model protects Golgi in cells and reduces the build-up of amyloid β, a primary component of Alzheimer’s disease.